CoChat

The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells

Open access
Kuczma, Michal P., Ding, Zhi-Chun, Li, Tao, Habtetsion, Tsadik, Chen, Tingting, Hao, Zhonglin, Bryan, Locke, Singh, Nagendra, Kochenderfer, James N., Zhou, Gang · 2017 · Oncotarget
Cited by 75

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

// Michal P. Kuczma 1, 6 , Zhi-Chun Ding 1 , Tao Li 2 , Tsadik Habtetsion 1 , Tingting Chen 1 , Zhonglin Hao 1 , Locke Bryan 3 , Nagendra Singh 4 , James N. Kochenderfer 5 and Gang Zhou 1 1 Georgia Cancer Center, Augusta University, Augusta, Georgia, USA 2 Department of Oncology and Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, PR China 3 Hematology/Oncology, Georgia Cancer Center, Augusta University, Augusta, Georgia, USA 4 Department of Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, USA 5 Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, Maryland, USA 6 Current/Present address: Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA Correspondence to: Gang Zhou, email: GZHOU@augusta.edu Keywords: antibiotics; intestinal microbiota; cyclophosphamide; chimeric antigen receptor; adoptive T-cell therapy Received: September 12, 2017 Accepted: November 26, 2017 Published: December 05, 2017 ABSTRACT In recent years the combined use of chemotherapy and immunotherapy, collectively termed chemoimmunotherapy, has emerged as a promising treatment option for patients with cancer. Antibiotics are commonly used to reduce infection-related complications in patients undergoing chemotherapy. Intriguingly, accumulating evidence has implicated gut microbiota as a critical determinant of host antitumor immune responses, raising the question as to whether the use of broad-spectrum antibiotics would invariably diminish tumor response to chemoimmunotherapies. We investigated the impact of antibiotics on the therapeutic outcomes of cyclophosphamide (CTX) chemotherapy and adoptive T-cell therapy (ACT) where CTX was used as the host-conditioning regimen in mice. We show that antibiotic prophylaxis dampened the endogenous T cell responses elicited by CTX, and reduced the efficacy of CTX against B-cell lymphoma. In the ACT setting, antibiotics administration impaired the therapeutic effects of adoptively transferred tumor-specific CD4+ T cells in mice with implanted colorectal tumors. In contrast, long-term antibiotic exposure did not affect the efficacy of ACT using CD19-targeting chimeric antigen receptor (CAR) T cells in mice with systemic B-cell lymphoma, although it correlated with prolonged CAR expression and sustained B-cell aplasia. Our study demonstrates that chemoimmunotherapies may have variable reliance on intestinal microbiota for T cell activation and function, and thus have different sensitivities to antibiotic prophylaxis. These findings may have implications for the judicial use of antibiotics in cancer patients receiving chemoimmunotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.22953

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 75

Metadata

Authors
Kuczma, M. P., Ding, Z.-C., Li, T., Habtetsion, T., Chen, T., Hao, Z., Bryan, L., Singh, N., Kochenderfer, J. N., & Zhou, G.
Venue
Oncotarget
Published
2017-12-05
Volume
8
Issue
67
Pages
111931-111942
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2774227552
Cited by
75
References
11
FWCI
2.91
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. https://app.cochat.ai/papers/10.18632/oncotarget.22953
The paper
Kuczma, M. P., Ding, Z.-C., Li, T., Habtetsion, T., Chen, T., Hao, Z., Bryan, L., Singh, N., Kochenderfer, J. N., & Zhou, G. (2017). The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget. https://doi.org/10.18632/oncotarget.22953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.